Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
Authors
Hyejoo Park (ORCID: https://orcid.org/0000-0002-7511-864X)
Joo-Hang Kim (ORCID: https://orcid.org/0000-0003-0408-8997)
Ki Hyeong Lee (ORCID: https://orcid.org/0000-0002-7830-5950)
Yun‐Gyoo Lee (ORCID: https://orcid.org/0000-0002-2156-5081)
Ji‐Youn Han (ORCID: https://orcid.org/0000-0001-5033-0006)
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
Hyejoo Park, Joo-Hang Kim, Ki Hyeong Lee, Yun‐Gyoo Lee et al.
Citations
7 citations
Journal
BMC Medicine
Topics
Lung Cancer Treatments and Mutations
Field-Weighted Citation Impact (FWCI)
2.93
article
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
Hyejoo Park, Joo-Hang Kim, Ki Hyeong Lee, Yun‐Gyoo Lee, Ji‐Youn Han, Myung‐Ju Ahn, Gyeong‐Won Lee, Sang‐We Kim, Heewon Han, Byoung Chul Cho, Na Mi Lee, Dong‐Wan Kim, Jieon Lee, Eun Kyung Cho, Young Joo Min, Sung Sook Lee, Hyun Woo Jang
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 22(1)
Institutions
Ulsan College (KR), Yuhan University (KR), Yonsei University (KR), Asan Medical Center (KR), Samsung Medical Center (KR), Seoul National University Hospital (KR), University of Ulsan (KR), Gachon University Gil Medical Center (KR), National Cancer Center (US), Gyeongsang National University Hospital (KR), Inje University Haeundae Paik Hospital (KR), Kangbuk Samsung Hospital (KR), National Cancer Center (KR), CHA University Bundang Medical Center (KR), Ulsan University Hospital (KR), CHA University (KR), Chungbuk National University Hospital (KR), Sungkyunkwan University (KR)